By Dr Ingrid Alida Van Beek

Books

Shearer J; Wodak AD; Mattick RP; Van Beek IA; Lewis J; Dolan K, 1999, A randomised controlled trial of the feasibility of monitoring controlled prescribing of dexamphetamine, Original, National Drug & Alcohol Research Centre, Randwick, NSW

Book Chapters

Post JJ; Marinos G; Van Beek IA; Burns M, 2008, 'Exposure and acute viral hepatitis', in HIV, viral hepatitis and STIs - a guide for primary care, edn. 3rd edition, ASHM Australasian Society for HIV Medicine, Darlinghurst, pp. 54 - 62

Van Beek IA, 2002, 'Injecting drug users', in World Health Organization (ed.), Scaling up Antiretroviral Therapy in resource-limited settings, edn. 1st, World Health Organisation, Geneva, pp. 76 - 79

Post JJ; Van Beek IA; Burns MG; Marinos G, 2001, 'Exposure and acute viral hepatitis', in Dore G; Grulich A; Kidd M; Hoy J; McCoy R; Mijch A; Strasser S (ed.), Chapter 5: Blood Borne Viruses: A Guide for Primary Care Practitioners, edn. Original, Australasian Society for HIV Medicine Monograph, Sydney, Australia, pp. 37 - 45

Journal articles

Dietze P; Jauncey M; Salmon A; Mohebbi M; Latimer J; Van Beek I; McGrath C; Kerr D, 2019, 'Effect of Intranasal vs Intramuscular Naloxone on Opioid Overdose: A Randomized Clinical Trial', JAMA Network Open, 2, http://dx.doi.org/10.1001/jamanetworkopen.2019.14977

Dwyer R; Olsen A; Fowlie C; Gough C; van Beek I; Jauncey M; Lintzeris N; Oh G; Dicka J; Fry CL; Hayllar J; Lenton S, 2018, 'An overview of take-home naloxone programs in Australia', Drug and Alcohol Review, 37, pp. 440 - 449, http://dx.doi.org/10.1111/dar.12812

Dietze PM; Draper B; Olsen A; Chronister KJ; van Beek I; Lintzeris N; Dwyer R; Nelson M; Lenton S, 2018, 'Does training people to administer take-home naloxone increase their knowledge? Evidence from Australian programs', Drug and Alcohol Review, 37, pp. 472 - 479, http://dx.doi.org/10.1111/dar.12680

Chronister KJ; Lintzeris N; Jackson A; Ivan M; Dietze PM; Lenton S; Kearley J; van Beek I, 2018, 'Findings and lessons learnt from implementing Australia's first health service based take-home naloxone program', Drug and Alcohol Review, 37, pp. 464 - 471, http://dx.doi.org/10.1111/dar.12400

Read P; Lothian R; Chronister K; Gilliver R; Kearley J; Dore GJ; van Beek I, 2017, 'Delivering direct acting antiviral therapy for hepatitis C to highly marginalised and current drug injecting populations in a targeted primary health care setting', International Journal of Drug Policy, 47, pp. 209 - 215, http://dx.doi.org/10.1016/j.drugpo.2017.05.032

Doyle JS; Grebely J; Spelman T; Alavi M; Matthews GV; Thompson AJ; Dore GJ; Hellard ME; Kaldor J; Marks P; Lloyd A; Haber P; French R; White P; Rawlinson W; Day C; Van Beek I; McCaughan G; Madden A; Dolan K; Farrell G; Crofts N; Sievert W; Baker D, 2016, 'Quality of life and social functioning during treatment of recent hepatitis C infection: A multi-centre prospective cohort', PLoS ONE, 11, pp. e0150655, http://dx.doi.org/10.1371/journal.pone.0150655

van Beek I; Chronister KJ, 2016, 'Needs-based public health service provision ensures equity', International Journal of Drug Policy, 31, pp. 201 - 202, http://dx.doi.org/10.1016/j.drugpo.2016.02.014

Ivan M; Rodgers C; Maher L; Van Beek I, 2016, 'Reducing injecting-related injury and diseases in people who inject drugs: Results from a clinician-led brief intervention', Australian Family Physician, 45, pp. 129 - 133

Kirwan A; Curtis M; van Beek IA; Cantwell K; Dietze PM, 2016, 'Take-home naloxone programs and calls to emergency services', Medical Journal of Australia, 204, pp. 143 - 143.e1, http://dx.doi.org/10.5694/MJA15.00783

Day CA; Shanahan M; Wand H; Topp L; Haber PS; Rodgers C; Deacon R; Walsh N; Kaldor J; van Beek I; Maher L; Day C; Lloyd A; Dore GJ; Walsh N, 2016, 'Development of immunity following financial incentives for hepatitis B vaccination among people who inject drugs: A randomized controlled trial', Journal of Clinical Virology, 74, pp. 66 - 72, http://dx.doi.org/10.1016/j.jcv.2015.11.031

Alavi M; Spelman T; Matthews GV; Haber PS; Day C; van Beek I; Walsh N; Yeung B; Bruneau J; Petoumenos K; Dolan K; Kaldor JM; Dore GJ; Hellard M; Grebely J; Marks P; Amin J; Doab A; Carroll T; Teutsch S; Li H; Oon A; Cameron B; Lloyd A; White P; Rawlinson W; Jacqueline Flynn ; Goy K; Nguyen O; von Bibra S; Ffrench R; McCaughan G; Madden A; Farrell G; Crofts N; Sievert W; Baker D; Jacka B; Pan Y; Shaw D; Sasadeusz J; Crawford D; Phung N; George J; Bloch M; Hughes B; Mollison L; Roberts S; Desmond P; Acraman B, 2015, 'Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C', International Journal of Drug Policy, 26, pp. 976 - 983, http://dx.doi.org/10.1016/j.drugpo.2015.05.003

van Beek I; Chronister KJ, 2015, 'Performance and image enhancing drug injectors' access to needle syringe programs: Responding to a public policy dilemma', International Journal of Drug Policy, 26, pp. 868 - 874, http://dx.doi.org/10.1016/j.drugpo.2015.05.009

Ivan M; Van Beek I; Wand H; Maher L, 2015, 'Surveillance of injecting-related injury and diseases in people who inject drugs attending a targeted primary health care facility in Sydney's Kings Cross', Australian and New Zealand Journal of Public Health, 39, pp. 182 - 187, http://dx.doi.org/10.1111/1753-6405.12363

Haber PS; Day CA; Topp L; Shanahan M; Wand H; Van Beek I; Maher L, 2015, 'Hepatitis B vaccination for people who inject drugs', The Lancet, 385, pp. 115, http://dx.doi.org/10.1016/s0140-6736(15)60019-8

Chronister KJ; Kearley J; Jackson A; Ivan M; Leung S; Lintzeris N; Van Beek I, 2014, 'EVALUATION OF A PEER NALOXONE DISTRIBUTION PROJECT IN SYDNEY, AUSTRALIA, 2012-2014', DRUG AND ALCOHOL REVIEW, 33, pp. 21 - 21, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344914800061&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Van Beek I; Tayler P; Chronister KJ, 2014, 'PERFORMANCE AND IMAGE ENHANCING DRUGS INJECTORS' ACCESS TO NEEDLE SYRINGE PROGRAMS - A PUBLIC POLICY DILEMMA', DRUG AND ALCOHOL REVIEW, 33, pp. 59 - 60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344914800171&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Rodgers C; Ivan M; Maher L; Van Beek I, 2014, 'REDUCING INJECTING-RELATED INJURY AND DISEASES IN PEOPLE WHO INJECT DRUGS - RESULTS OF A PILOT CLINICIAN-LED INTERVENTION', DRUG AND ALCOHOL REVIEW, 33, pp. 53 - 53, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344914800153&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Topp LJ; Day C; Wand HC; Deacon RM; Van Beek IA; Haber PS; Shanahan MD; Rodgers CJ; Maher L, 2013, 'A randomised controlled trial of financial incentives to increase hepatitis B vaccination completion among people who inject drugs in Australia', Preventive Medicine, Advance online publication, pp. 1 - 7, http://dx.doi.org/10.1016/j.ypmed.2013.04.013

Deacon RM; Topp L; Wand HC; Day C; Rodgers C; Haber P; van Beek I; Maher L, 2012, 'Correlates of susceptibility to hepatitis b among people who inject drugs in Sydney, Australia', Journal of Urban Health - Bulletin of the New York Academy of Medicine, 89, pp. 769 - 778, http://dx.doi.org/10.1007/s11524-012-9680-z

Grebely J; Matthews GV; Petoumenos K; Yeung B; Day C; Lloyd AR; Beek IV; Kaldor JM; Hellard M; Dore GJ; Haber PS; Alavi M; Van Beek I; Amin J; Dolan K; Rawlinson W; Flynn J; Marks P; Acraman B; Bloch M; Li H; Madden A; George J, 2012, 'Effect of pegylated interferon-a-2a treatment on mental health during recent hepatitis C virus infection', Journal of Gastroenterology and Hepatology, 27, pp. 957 - 965, http://dx.doi.org/10.1111/j.1440-1746.2011.07035.x

van Beek I, 2012, 'Maybe not perfect-but surely good enough?', Int J Drug Policy, 23, pp. 108, http://dx.doi.org/10.1016/j.drugpo.2011.09.011

VAN BEEK I, 2012, 'Response to Islam et al.: Opportunistic and continuing health care for injecting drug users from a nurse‐run needle syringe program‐based primary health‐care clinic', Drug and Alcohol Review, 31, pp. 116 - 117, http://dx.doi.org/10.1111/j.1465-3362.2011.00389.x

Islam MM; Topp L; Conigrave KM; van Beek I; Maher L; White A; Rodgers C; Day C, 2012, 'The reliability of sensitive information provided by injecting drug users in a clinical setting: Clinician-administered versus audio computer-assisted self-interviewing (ACASI)', AIDS Care - Psychological and Socio - Medical Aspects of AIDS/HIV, 24, pp. 1496 - 1503, http://dx.doi.org/10.1080/09540121.2012.663886

Topp L; Day C; Wand H; Deacon R; Van Beek I; Haber P; Shanahan M; Rodgers C; Maher L, 2011, 'A RANDOMISED CONTROLLED TRIAL OF CONTINGENCY MANAGEMENT TO INCREASE HEPATITIS B VACCINATION UPTAKE AND COMPLETION AMONG PEOPLE WHO INJECT DRUGS IN AUSTRALIA', DRUG AND ALCOHOL REVIEW, 30, pp. 86 - 87, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000297019700266&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Grebely J; Matthews G; Hellard M; Shaw D; van Beek I; Petoumenos K; Alavi M; Yeung B; Haber P; Lloyd AR; Kaldor JM; Dore GJ; Dolan K, 2011, 'Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users', Journal of Hepatology, 55, pp. 76 - 85, http://dx.doi.org/10.1016/j.jhep.2010.10.033

Jauncey ME; Van Beek IA; Salmon AM; Maher L, 2011, 'Bipartisan support for Australia’s supervised injecting facility: a decade in the making.', Medical Journal of Australia, 195, pp. 264, http://dx.doi.org/10.5694/mja11.10815

Matthews G; Pham STP; Hellard M; Grebely J; Zhang L; Oon A; Marks P; Van Beek IA; Rawlinson WD; Kaldor JM; Lloyd AR; Dore GJ; White PA, 2011, 'Patterns and characteristics of Hepatitis C transmission clusters among HIV-positive and HIV-negative individuals in the Australian Trial in Acute Hepatitis C', Clinical Infectious Diseases, 52, pp. 803 - 811, http://dx.doi.org/10.1093/cid/ciq200

Shearer J; Shanahan MD; Darke S; Rodgers CJ; Van Beek IA; McKetin R; Mattick RP, 2010, 'A cost-effectiveness analysis of modafinil therapy for psychostimulant dependence', Drug and Alcohol Review, 29, pp. 235 - 242, http://dx.doi.org/10.1111/j.1465-3362.2009.00148.x

Dore GJ; Hellard M; Matthews G; Grebely J; Haber PS; Petoumenos K; Yeung B; Marks P; Van Beek IA; McCaughan G; White PA; French R; Rawlinson WD; Lloyd AROLA; Kaldor JM; Dolan K, 2010, 'Effective treatment of injecting drug users with recently acquired hepatitis C virus infection', Gastroenterology, 138, pp. 123 - 135, http://dx.doi.org/10.1053/j.gastro.2009.09.019

Day C; White B; Dore G; Van Beek I; Rodgers C; Cunningham P; Wodak A; Maher L, 2010, 'Hepatitis B virus among injecting drug users in Sydney, Australia: Prevalence, vaccination and knowledge of status', Drug and Alcohol Dependence, 108, pp. 134 - 137, http://dx.doi.org/10.1016/j.drugalcdep.2009.11.013

Grebely J; Petoumenos K; Hellard M; Matthews G; Suppiah V; Applegate TL; Yeung B; Marks P; Rawlinson WD; Lloyd AROLA; Booth D; Kaldor JM; George J; Dore GJ; Amin J; Cameron B; Acraman B; Dolan K; Bloch M; Van Beek I; Li H; Madden A, 2010, 'Potential Role for Interleukin-28B Genotype in Treatment Decision-Making in Recent Hepatitis C Virus Infection', Hepatology, 52, pp. 1216 - 1224, http://dx.doi.org/10.1002/hep.23850

Salmon A; Van Beek I; Amin J; Kaldor JM; Maher L, 2010, 'The impact of a supervised injecting facility on ambulance call-outs in Sydney, Australia', Addiction, 105, pp. 676 - 683, http://dx.doi.org/10.1111/j.1360-0443.2009.02837.x

Shearer J; Darke S; Rodgers CJ; Slade T; Van Beek IA; Lewis J; Brady D; McKetin R; Mattick RP; Wodak AD, 2009, 'A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence', Addiction, 104, pp. 224 - 233, http://dx.doi.org/10.1111/j.1360-0443.2008.02437.x

Van Beek IA, 2009, 'Harm reduction - an ethical imperative', Addiction, 104, pp. 342 - 343, http://dx.doi.org/10.1111/j.1360-0443.2008.02418.x

Salmon A; Van Beek I; Amin J; Grulich A; Maher L, 2009, 'High HIV testing and low HIV prevalence among injecting drug users attending the Sydney Medically Supervised Injecting Centre', Australian and New Zealand Journal of Public Health, 33, pp. 280 - 283, http://dx.doi.org/10.1111/j.1753-6405.2009.00389.x

Salmon A; Dwyer R; Jauncey M; Van Beek I; Topp L; Maher L, 2009, 'Injecting-related injury and disease among clients of a supervised injecting facility', Drug and Alcohol Dependence, 101, pp. 132 - 136, http://dx.doi.org/10.1016/j.drugalcdep.2008.12.002

Haber P; Hellard M; Matthews GV; Grebely J; Petoumenos K; Yeung B; Marks P; van Beek I; McCaughan G; White PA; Ffrench R; Rawlinson W; Lloyd A; Kaldor J; Dore GJ, 2009, 'Treatment of recent hepatitis C virus infection in a predominantly injection drug user cohort: the ATAHC Study', The Canadian Journal of Addiction, 1, pp. 33 - 33, http://dx.doi.org/10.1097/02024458-200912000-00072

White B; Day C; Thein H; Doab A; Bates A; Holden J; Van Beek I; Maher L, 2008, 'Acceptability of hepatitis C virus testing methods among injecting drug users', Drug and Alcohol Review, 27, pp. 666 - 670, http://dx.doi.org/10.1080/09595230801956116

Treloar C; Laybutt B; Jauncey ME; Van Beek IA; Lodge M; Malpas G; Carruthers S, 2008, 'Broadening discussions of `safe` in hepatitis C prevention: A close-up of swabbing in an analysis of video recordings of injecting practice', International Journal of Drug Policy, 19, pp. 59 - 65, http://dx.doi.org/10.1016/j.drugpo.2007.01.005

Kimber J; Hickman M; Degenhardt LJ; Coulson T; Van Beek IA, 2008, 'Estimating the size and dynamics of an injecting drug user population and implications for health service coverage: comparison of indirect prevalence estimation methods', Addiction, 103, pp. 1604 - 1613

Kimber J; Mattick RP; Kaldor JM; Van Beek IA; Gilmour S; Rance J, 2008, 'Process and predictors of drug treatment referral and referral uptake at the Sydney Medically Supervised Injecting Centre', Drug and Alcohol Review, 27, pp. 602 - 612

Degenhardt LJ; Roxburgh AD; Van Beek IA; Hall WD; Robinson M; Ross JE; Mant A, 2008, 'The effects of the market withdrawal of temazepam gel capsules on benzodiazepine injecting in Sydney, Australia', Drug and Alcohol Review, 27, pp. 145 - 151, http://dx.doi.org/10.1080/09595230701829413

van Beek I, 2007, 'Case study: accessible primary health care--a foundation to improve health outcomes for people who inject drugs.', Int J Drug Policy, 18, pp. 329 - 332, http://dx.doi.org/10.1016/j.drugpo.2006.11.005

Micallef JM; Macdonald V; Jauncey ME; Amin J; Rawlinson WD; Van Beek IA; Kaldor JM; White PA; Dore GJ, 2007, 'High Incidence of hepatitis C virus reinfection within a cohort of injecting drug users', Journal of Viral Hepatitis, 14, pp. 413 - 418

Amin J; Law MG; Micallef JM; Jauncey ME; Van Beek IA; Kaldor JM; Dore GJ, 2007, 'Potential biases in estimates of hepatitis C RNA clearance in newly acquired hepatitis C infection among a cohort of injecting drug users', Epidemiology and Infection, 135, pp. 144 - 150

Macdonald V; Dore GJ; Amin J; Van Beek IA, 2007, 'Predictors of completion of a hepatitis Bvaccination schedule in attendees at a primary health care centre.', Sexual Health, 4, pp. 27 - 30

Back to profile page